Download fulltext HTML
1.
Luong Hien D. How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?. JOVR [Internet]. 2020Oct.25 [cited 2024Apr.18];15(4):442–445. Available from: https://knepublishing.com/index.php/JOVR/article/view/7777

https://doi.org/10.18502/jovr.v15i4.7777

statistics

  • 747 Abstract Views
  • 423 PDF Views
  • 0 HTML Views

authors

  • Doan Luong Hien

    Doan Luong Hien

    Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California, USA; Pham Ngoc Thach University of Medicine, Saigon, Vietnam

Published Date

  • Oct 25, 2020
This journal is publishing all the articles under Creative Commons Attribution License CC BY 4.0.

How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?

Journal of Ophthalmic and Vision Research (JOVR) / October–December 2020, Volume 15, Issue 4 / Pages 442–445

Abstract

This is an Editorial and does not have an abstract.

Keywords:

NA